[1] Lukasiewicz S,Czeczelewski M,Forma A,Baj J,Sitarz R,Stanislawek A .2021 .Breast cancer-epidemiology, risk factors, classi cation, prognostic markers, and current treatment strategies-an updated review. Cancers, 10(17) : 4287.
[2] Mehdi I,Monem AA,Al Bahrani B,Ramadhan FA .2014 .Breast cancer molecular subtypes in Oman: Correlation with age, histology, and stage distribution - analysis of 542 cases. Gulf J Oncolog, 1(15) : 38-48.
[3] Burguin A,Diorio C .2021 .Breast cancer treatments: Updates and new challenges. J Pers Med, 10(8) : 808.
[4] Ribnikar D,Ribeiro JM,Pinto D,Sousa B,Pinto AC,Gomes E . .Breast cancer under age 40: A di erent approach. Curr Treat Options, 10(4) : 16.
[5] Layse de Menezes Dantas M,Hugo da Silva Santos Y,Alcantara da Silva PH,Medeiros de Azevedo F,Petta TB .2021 .Prevalence of extracapsular extension in metastatic sentinel lymph nodes in breast cancer. Surg Oncol, 101594 : 101594.
[6] Nowikiewicz T,Kurylcio A,Glowacka-Mrotek I,Szymankiewicz M,Novikiewicz M,Zegarski W. .2021 .Clinical relevance of a degree of extracapsular extension in a sentinel lymph node in breast cancer patients: A single-centre study. Sci Rep, 10(1) : 8982.
[7] Maraz R,Venczel L,Sikorszki L,Ambrozay E,Serfoza O,Rajtar M .2020 .The importance of the extracapsular extension of the sentinel node metastasis in the surgical treatment of breast cancer. Magy Seb, 1(1) : 16-22.
[8] Freitas GB,Mota BS,Maesaka JY,Pinheiro CC,de Lima LGCA,Soares JM .2023 .Measurement of extracapsular extension in sentinel lymph node as a possible predictor of residual axillary disease in breast cancer. Clinics (Sao Paulo), 100216 : 100216.
[9] Bi WL,Hosny A,Schabath MB,Giger M,Birkbak NJ,Mehrtash A .2019 .Arti cial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin, 10(2) : 127-57.
[10] Hosny A,Parmar C,Quackenbush J,Schwartz LH,Aerts HJWL .2018 .Arti cial intelligence in radiologyN. at Rev Cancer, 10(8) : 500-10.
[11] Russo L,Charles-Davies D,Bottazzi S,Sala E,Boldrini L,Oncol (R Coll Radiol L .2024 .Radiomics for clinical decision support in radiation oncology. , 03(8) : e269-81.
[12] Nie K,Al-Hallaq H,Li XA,Benedict HS,Sohn JW,Moran JM .2019 .NCTN assessment on current applications of radiomics in oncology. Int J Radiat Oncol Biol Phys, 01(2) : 302-15.
[13] Schick U,Lucia F,Bourbonne V,Dissaux G,Pradier O,Jaouen V .2020 .Use of radiomics in the radiation oncology setting: Where do we stand and what do we need?. Cancer Radiother, 07(6-7) : 755-61.
[14] Aerts HJ,ER HJ,Chintan RT,Patrick P,Sara G,C G .2014 .Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun, 10(1) : 4006.
[15] Lambin P,Valezquez ER,Leijenaar R,Carvalho S,Van Striphout RG,Granton P .2011 .Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer, 11(4) : 441-6.
[16] Fournier L,Costaridou L,Bidaut L,Michoux N,Lecouvet FE,de Geus-Oei LF .2021 .Incorporating radiomics into clinical trials: Expert consensus endorsed by the European society of radiology on considerations for data-driven compared to biologically driven quantitative biomarkers. Eur Radiol, 10(8) : 6001-12.
[17] Guo X,Liu Z,Sun C,Zhang L,Wang Y,Li Z .2020 .Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer. EBioMedicine, 103018 : 103018.
[18] Hwang JP,Choi JY,Choi JH,Cho YS,Hur SM,Kim Z .2022 .Prognostic value of axillary lymph node texture parameters measured by pretreatment 18f- uorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer with neoadjuvant chemotherapy. Diagnostics, 10(10) : 16012.
[19] Li H,Zhu Y,Burnside ES,Huang E,Drukker K,Hoadley KA .2016 .Quantitative MRI radiomics in the prediction of molecular classi cations of breast cancer subtypes in the TCGA/TCIA data set. NPJ Breast Cancer, 12(1) : 16012.
[20] Shigematsu H,Taguchi K,Koui H,Onho S. .2015 .Clinical signi cance of extracapsular 1nvasion at sentinel lymph nodes in breas cancer patients with sentinel lymph node 1nvolvement. Ann Surg Oncol, 10(7) : 2365-71.